Cross sections of 225Ac, 227Ac, 227Th and 228Th in thorium-232 targets irradiated with protons in the energy range 21–141 MeV have been measured. Based on these data, production yields of 225Ac and 223Ra in thick thorium targets have been calculated. It is possible to produce in proton energy range 60–140 MeV about 96 GBq (2.6 Ci) 225Ac per 10-d irradiation with 100 μA proton beam current and 10-d decay, and much higher amount of 223Ra. The impurities of 227Ac and 224Ra are important and need to be assessed for further medical applications.
The possibility of producing 225Ac and 223Ra by irradiation of natural 232Th with medium-energy protons was examined. Thorium foils were irradiated with 90-, 110-, and 135-MeV protons at the accelerator of the Institute for Nuclear Research, Russian Academy of Sciences, in Troitsk (Moscow oblast). The cumulative production cross sections for 225Ac were 6.7 ± 0.9, 9.8 ± 1.9, and 13.9 ± 1.5 mb, and for 227Th (223Ra precursor), 43 ± 5, 37 ± 6, and 35 ± 4 mb, respectively. Based on the experimental data and theoretical calculations, the possible yields of 225Ac and 223Ra in irradiation of thick thorium targets at various accelerators were determined. An efficient procedure was suggested for isolating the products from the irradiated targets: 225Ac, by liquid extraction and extraction chromatography, and 223Ra, by sublimation from a thorium-lanthanum melt followed by thermochromatographic separation in metallic titanium columns and extraction-chromatographic isolation of radium. The procedure allows production of large (units of curies) amounts of radiochemically pure 225Ac and 223Ra, which is promising for wide use of these radionuclides in nuclear medicine.
6 June 2014 in Solvent Extraction and Ion Exchange
A method of isolation of actinium-225 for nuclear medical applications from thorium targets irradiated by protons is presented. It comprises liquid extraction and extraction chromatography separations. The method demonstrates high (> 85%) chemical yield and radionuclide purity of the final product. An impurity of 227Ac (0.1% at the end of bombardment) does not hinder 225Ac from being used for medical 225Ac/213Bi generators.
The surface-mediated reduction of Pu(VI) upon sorption onto hematite colloids is addressed in the paper that bring some new light on the mechanisms of interaction of Pu in high valence states with different Fe(III) oxides. We study the sorption of Pu taken at two different total concentrations around 10−9 and 10−14 M using 239Pu and short-lived 237Pu tracer. In order to conclude on the mechanisms of Pu sorption onto hematite, the kinetics of sorption of Pu(IV) and Pu(VI) at two concenrations is studied as well as its leching behavior. The rate limiting step in Pu(VI) sorption is its surface-mediated reduction. The experimental evidence of the polymerization of Pu(IV) on the surface taken at Pu total concentration of ∼10−9 M is presented based on the kinetics of sorption and leaching behavior.
10 July 2007 in Journal of Radioanalytical and Nuclear Chemistry
Method for production of alpha emitter 149Tb by irradiation of 151Eu with 70 MeV 3He nuclei is proposed. For the first time, the cross sections for the formation of isotopes 149,150,151,152Tb were measured experimentally using a stack foil technique in the 3He particles energy range 70 → 12 MeV. The thick target yield of 149Tb is 39 MBq/μAh, or 230 MBq/μA 149Tb at saturation. The optimal energy range from the point of view of radioisotopic purity is 70 → 40 MeV. At these conditions about 150 MBq/μA 149Tb can be produced in 8 hours irradiation, which is sufficient for therapeutic applications. The main impurities are 150Tb (~100% in activity) and 151Tb (~30% in activity). The proposed method surpasses its counterparts by the high content of the target isotope in the natural mixture and the simplicity of the radiochemical separation of 149Tb from the bulk target material.